皮下注射針の世界市場予測（2022年～2027年）

世界の皮下注射針の市場規模は、2020年に25億6,192万8,000米ドルとなり、予測期間中に7.38％のCAGRで推移し、2027年には42億1,726万4,000米ドルに達すると予測されています。

当レポートでは、世界の皮下注射針市場を調査し、市場規模や予測、市場の促進要因および課題、市場動向、タイプ別・用途別・エンドユーザー別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• 業界のバリューチェーン分析

第5章 世界の皮下注射針市場分析：タイプ別

• イントロダクション
• 安全皮下注射針
• 非安全皮下注射針

第6章 世界の皮下注射針市場分析：用途別

• イントロダクション
• ワクチン
• ドラッグデリバリー
• 体液サンプル収集

第7章 世界の皮下注射針市場分析：エンドユーザー別

• イントロダクション
• 病院・クリニック
• 外来診療センター

第8章 世界の皮下注射針市場分析：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • その他
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 台湾
  • インドネシア
  • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の収益性
• 合併、買収、合意、およびコラボレーション
• ベンダー競争力マトリックス

第10章 企業プロファイル

• B. Braun Melsungen AG
• NIPRO
• Cardinal Health Inc.
• Terumo Medical Corporation
• Smiths Group Plc
• BD
• Iscon Surgicals Ltd.
• Narang Medical Ltd.
• Medline Industries Inc.
• Dynarex Corporation

The hypodermic needle market is expected to grow at a compound annual growth rate of 7.38% over the forecast period to reach a market size of US$4,217.264 million in 2027, from US$2,561.928 million in 2020.

Increasing prevalence of diabetes

The market is expected to surge in the coming years, due to the rise and growth in the prevalence rate of diabetes, worldwide. According to the data given by the International Diabetes Federation, around 537 million adults have been living with diabetes for years, between the ages of 20 and 79 category. Moreover, it has also been estimated that the global population living with diabetes is expected to grow to 643 million by 2030 and around 783 million by 2045. Increasing global expenditure on diabetes had been expected to surge the adoption of advanced drug delivery solutions. Around US$966 billion is usually spent on diabetes annually, worldwide. Various companies and corporations have been offering advanced and novel solutions for diabetic patients, such as the easy delivery of drugs by needles in a patient's body. For instance, Terumo Corporation has been providing painless needles to its customers worldwide. The company had also sourced intellectual property rights to provide itself with a competitive advantage and safeguard its manufacturing and production process of needles.

Competitive Analysis

Several firms and corporations have been making a considerable impact in the market in the past few years. The increasing expenditure on research and development had been expected to surge in the next few years, as the corporations tend to increase their competitive advantage and overall market share, globally. Iscon Surgicals Ltd., one of the key players in the market, has been providing and selling disposable hypodermic needles to its customers. The company had stated that their needle had been produced through high and advanced precision grinding, siliconization, and ultrasonic cleaning. The company's products have been ISO Certified. Other corporations have been offering advanced hypodermic needles for their customers. For instance, NIPRO, one of the largest needles manufacturers, produces around 11 billion units annually. The company had stated that its products are not manufactured as PVC or latex. It also offers hypodermic needles in different lengths and sizes. These developments and trends are expected to play a significant role in the market during the forecast period.

The increasing rate of asthma

Hypodermic needle consumption and use have been expected to surge in the coming years due to the increasing rate of asthma, worldwide. According to the data given by the World Health Organisation, around 262 million were affected by asthma in the year 2019. It has also caused an estimated 461,000 deaths globally. With the increase in healthcare expenditure, there has been a surge in the adoption of advanced and high-quality needles and syringes worldwide. The World Health Organisation has also been undertaking several measures to enhance the drug delivery sector in lower and middle-income countries. With the increasing industrialization, there has been a concern of high pollution, which had been one of the major factors in the increasing prevalence rate of asthmatic patients. Therefore, it is expected to enhance the adoption of hypodermic needles and other drug delivery products in the coming years.

Favorable Government Regulations

Several patients suffering from diabetes and asthma have been consuming and using hypodermic needles on their own. These patients are required to desensitize drugs and injections in case of different allergic reactions. Governments worldwide have been easing the regulations and laws that allow patients to carry hypodermic needles without any major restrictions. For instance, in March 2021, Maryland Senate in the United States announced the passing of a novel bill decriminalizing the distribution and possession of hypodermic needles. Moreover, in October 2021, the New York Government announced the passing of a bill decriminalizing the distribution and sales of hypodermic needles in the state. Under this novel bill, hypodermic needles would not be considered as drug paraphernalia. The government had stated that the novel bill had been introduced to enhance the accessibility of the drug delivery systems to its people.

The increasing rate of chronic diseases

The market is expected to surge in the coming years, due to the rise in the prevalence rate of chronic diseases, worldwide. According to the data given by the World Health Organisation, the prevalence rate of chronic diseases was expected to grow by 57% by 2020. This development had been expected to surge the adoption of advanced needles and syringes that could safely deliver drugs into the body. Moreover, increasing vaccination rates were also expected to enhance the demand for novel injectable solutions, worldwide.

Segmentation:

• By Type

Safety Hypodermic Needle

Non-Safety Hypodermic Needle

• By Application

Vaccination

Drug delivery

Body Fluid Sample Collection

• By End Users

Hospitals and Clinics

Ambulatory Care Centers

• By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• UK
• Germany
• France
• Italy
• Others

Middle East and Africa

• Saudi Arabia
• South Africa
• Others

Asia Pacific

• Japan
• China
• India
• South Korea
• Thailand
• Taiwan
• Indonesia
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Hypodermic Needle Market Analysis, By Type 

• 5.1. Introduction
• 5.2. Safety Hypodermic Needle
• 5.3. Non-Safety Hypodermic Needle

6. Global Hypodermic Needle Market Analysis, By Application

• 6.1. Introduction
• 6.2. Vaccination
• 6.3. Drug delivery
• 6.4. Body Fluid Sample Collection

7. Global Hypodermic Needle Market Analysis, By End Users

• 7.1. Introduction
• 7.2. Hospitals and Clinics
• 7.3. Ambulatory Care Centers

8. Global Hypodermic Needle Market Analysis, By Geography 

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. UK
  • 8.4.2. France
  • 8.4.3. Germany
  • 8.4.4. Italy
  • 8.4.5. Others
• 8.5. Middle East and Africa 
  • 8.5.1. Saudi Arabia
  • 8.5.2. South Africa
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Thailand
  • 8.6.5. Taiwan
  • 8.6.6. Indonesia
  • 8.6.7. Others

9. Competitive Environment and Analysis

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. Company Profiles

• 10.1. B. Braun Melsungen AG
• 10.2. NIPRO
• 10.3. Cardinal Health Inc.
• 10.4. Terumo Medical Corporation
• 10.5. Smiths Group Plc
• 10.6. BD
• 10.7. Iscon Surgicals Ltd.
• 10.8. Narang Medical Ltd.
• 10.9. Medline Industries Inc.
• 10.10. Dynarex Corporation